Impact of High-fat Meals Varying in Fatty Acid Composition on Adipose and Systemic Metabolic-inflammatory Responses
NCT ID: NCT03712579
Last Updated: 2022-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2019-01-21
2020-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Consuming a diet rich in SFA may lead to a greater metabolic-inflammatory response in white adipose tissue during the fasting state, when compared to eating a diet rich in monounsaturated fatty acids (MUFA). Since individuals spend most of the day in the fed (or postprandial) state, it is important to see how different types of dietary fatty acids affect postprandial white adipose tissue and systemic metabolic-inflammatory responses.
This study will investigate the effect of a SFA-rich meal on markers of white adipose tissue and systemic metabolic-inflammation, compared to a MUFA-rich meal in overweight adults. In a randomised, single blind controlled, cross-over manner participants will consume either a SFA- or MUFA-rich meal and sequential blood and white adipose tissue samples will be collected before and until 6 hours postprandially.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Monounsaturated Fatty Acids on Intestinal Lipid Metabolism in Insulin Resistant Subjects (MUFA )
NCT03872349
Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers
NCT00233311
Postprandial Response After Intake of Meals With Different Fatty Acid Composition
NCT02729857
Effects of Dietary Fats on Cardiovascular Health and Insulin Sensitivity in Subjects With Abdominal Obesity
NCT01665482
Chronic Effects of Fats on Satiety & Energy Needs
NCT03236181
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SFA-Rich Meal
Participants will consume a SFA-rich test meal (75g test fat) and sequential blood and white adipose tissue samples will be collected
SFA-Rich Meal
Saturated fatty acid-rich test meal, containing 75g test fat
MUFA-Rich Meal
Participants will consume a MUFA-rich test meal (75g test fat) and sequential blood and white adipose tissue samples will be collected
MUFA-Rich Meal
Monounsaturated fatty acid-rich test meal, containing 75g test fat
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SFA-Rich Meal
Saturated fatty acid-rich test meal, containing 75g test fat
MUFA-Rich Meal
Monounsaturated fatty acid-rich test meal, containing 75g test fat
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI = 25-40 kg/m2
* Male or Female
* Waist circumference \>94 cm (men) and \>80cm (women)\*
* Physically active (\> 3 x 30 min moderate intensity exercise per week)
* Systolic blood pressure \< 160 mmHg and diastolic blood pressure \< 100 mmHg
* No cardiometabolic (e.g. heart disease, high blood pressure, type 2 diabetes) or inflammatory illness
* NOTE: If waist circumference falls below 94 cm for men or 80cm for women but BMI is \>25 kg/m2 volunteers may still be recruited at the PI's discretion.
Exclusion Criteria
* Previous diagnosis of anaemia
* Women who are pregnant or lactating
* Taking medication known to interfere with study outcomes (e.g. treatment for hyperlidaemia, hypertension, inflammation or hypercoagulation) or prescribed antibiotics within the last 3 months
* Taking nutritional supplements known to interfere with study outcomes (e.g. fish oil or evening primrose oil)
* Unstable weight history (\>3 kg loss or gain in the previous 3 months)
* An allergy to lidocaine
* Those with known or suspected food intolerances, allergies or hypersensitivity to any components of the meal (e.g. lactose/wheat intolerance)
* Alcohol consumption \>28 units per week for a man or \>21 units per week for a woman
* Any other unusual medical history or diet and lifestyle habits or practices that would preclude volunteers from participating in a dietary intervention or metabolic study
* Parallel participation in another intervention study
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Loughborough University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Oonagh Markey
Vice-Chancellor's Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oonagh Markey, BSc, PhD
Role: PRINCIPAL_INVESTIGATOR
Loughborough University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loughborough University
Loughborough, Leicestershire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R18-P124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.